• 33020 Citations
  • 92 Scopus h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Shaji K Kumar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 27 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis

Sidana, S., Milani, P., Binder, M., Basset, M., Tandon, N., Foli, A., Dispenzieri, A., Gertz, M. A., Hayman, S. R., Buadi, F. K., Lacy, M. Q., Kapoor, P., Leung, N., Rajkumar, S. V., Merlini, G., Palladini, G. & Kumar, S. K., Apr 1 2020, In : Blood cancer journal. 10, 4, 41.

Research output: Contribution to journalArticle

Open Access
  • Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a ‘graft versus host’-like syndrome and poor outcomes

    Anagnostou, T., Sakemura, R., Forsman, C. L., Patnaik, M. S., Paludo, J., Gastineau, D. A., Buadi, F. K., Porrata, L. F., Kumar, S. K., Gertz, M. A., Lacy, M. Q., Dispenzieri, A., Gonsalves, W. I., Lehman, J. S., Hogan, W. J., Hashmi, S. K., Alkhateeb, H., Shah, M. V., Litzow, M. R. & Kenderian, S. S., Jan 1 2020, (Accepted/In press) In : Bone Marrow Transplantation.

    Research output: Contribution to journalLetter

    Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

    Muchtar, E., Gertz, M. A., Kourelis, T. V., Sidana, S., Go, R. S., Lacy, M. Q., Buadi, F. K., Dingli, D., Hayman, S. R., Kapoor, P., Leung, N., Fonder, A., Hobbs, M., Lisa Hwa, Y., Gonsalves, W., Warsame, R., Russell, S., Lust, J. A., Lin, Y., Zeldenrust, S. & 4 others, Rajkumar, S. V., Kyle, R. A., Kumar, S. K. & Dispenzieri, A., Apr 1 2020, In : Leukemia. 34, 4, p. 1135-1143 9 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma

    Di Bacco, A., Bahlis, N. J., Munshi, N. C., Avet-Loiseau, H., Masszi, T., Viterbo, L., Pour, L., Ganly, P., Cavo, M., Langer, C., Kumar, S. K., Rajkumar, S. V., Keats, J. J., Berg, D., Lin, J., Li, B., Badola, S., Shen, L., Zhang, J., Esseltine, D. L. & 4 others, Luptakova, K., van de Velde, H., Richardson, P. G. & Moreau, P., Jan 1 2020, (Accepted/In press) In : European Journal of Haematology.

    Research output: Contribution to journalArticle

    Open Access
  • Cost-effectiveness of once weekly carfilzomib 70 mg/m2 plus dexamethasone in patients with relapsed and refractory multiple myeloma in the United States

    Kumar, S. K., Majer, I., Panjabi, S., Medhekar, R., Campioni, M. & Dimopoulos, M. A., Jan 1 2020, (Accepted/In press) In : Expert Review of Hematology.

    Research output: Contribution to journalArticle